News

• US mixed upon Biden remarks, Fed input
  05/10/2022 / 22:00 - TeleTrader
•  
• US opens higher ahead of Biden's inflation remarks
  05/10/2022 / 15:31 - TeleTrader
•  
• Virtual Conference Brings Young Breast Cancer Survivors Together
  03/19/2022 / 12:00 - GlobeNewswire
•  
• Press Release: Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates
  03/16/2022 / 11:18 - GlobeNewswire
•  
• Epygenix Therapeutics Announces Appointment of Darren Cline as CEO
  03/15/2022 / 12:00 - GlobeNewswire
•  
• Fight Colorectal Cancer is demanding MORE from Congress this March
  03/01/2022 / 21:55 - GlobeNewswire
•  
• SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights
  02/24/2022 / 12:30 - GlobeNewswire
•  
• Genmab Publishes 2021 Annual Report
  02/16/2022 / 17:00 - GlobeNewswire
•  
• Dow falls 520 pts at close with inflation, Fed in focus
  02/10/2022 / 22:00 - TeleTrader
•  
• Dow plunges 270 pts at open after inflation data
  02/10/2022 / 15:30 - TeleTrader
•  
• Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
  02/08/2022 / 14:00 - GlobeNewswire
•  
• Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts
  01/10/2022 / 13:00 - GlobeNewswire
•  
• Recludix Pharma Launches with $60 Million Series A to Support Innovative Platform to Discover and Develop Novel SH2 Domain-Targeted Therapies for Cancer and Inflammatory Diseases; Appoints Dr. Nancy Whiting as CEO
  11/15/2021 / 14:00 - GlobeNewswire
•  
• Genmab Announces Financial Results for the First Nine Months of 2021
  11/10/2021 / 17:00 - GlobeNewswire
•  
• Neoleukin Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Update
  11/04/2021 / 21:05 - GlobeNewswire